海正药业 (600267.SH)

今开: 最高: 成交量:

昨收: 最低: 成交额:

+ 收藏

利润表(单季度)(海正药业)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2023年第三季度2023年第二季度2023年第一季度2022年第四季度2022年第三季度2022年第二季度2022年第一季度
上市前/上市后 上市后上市后上市后上市后上市后上市后上市后
报表类型 合并报表合并报表合并报表合并报表合并报表合并报表合并报表
一、营业总收入(元) 2,640,792,348.682,996,569,046.813,063,534,009.223,292,781,807.363,007,219,050.772,759,484,394.552,977,204,828.98
 营业收入(元) 2,640,792,348.682,996,569,046.813,063,534,009.223,292,781,807.363,007,219,050.772,759,484,394.552,977,204,828.98
二、营业总成本(元) 2,551,482,641.932,785,866,143.622,778,135,602.123,090,578,478.852,762,322,968.352,628,902,581.592,773,861,709.12
 营业成本(元) 1,566,046,271.091,710,774,407.251,830,728,132.671,841,844,272.921,724,607,558.981,625,491,383.421,806,730,841.48
 研发费用(元) 101,225,359.27113,670,086.5697,041,933.90142,294,910.67104,958,852.0398,152,938.4683,286,810.37
 营业税金及附加(元) 26,769,493.489,234,966.5423,767,446.0234,538,386.9027,800,339.4114,594,691.4330,363,662.76
 销售费用(元) 567,616,905.55688,291,209.16548,317,890.42684,750,825.54605,264,343.43578,541,105.77537,528,642.73
 管理费用(元) 243,540,898.97217,334,255.59222,386,372.59320,087,964.99244,167,037.45246,383,643.59241,529,246.29
 财务费用(元) 46,283,713.5746,561,218.5255,893,826.5267,062,117.8355,524,837.0565,738,818.9274,422,505.49
  其中:利息费用(元) 52,107,385.7057,971,561.6056,524,961.9263,750,289.7264,577,007.5677,690,068.6877,106,415.17
  其中:利息收入(元) 6,376,270.715,765,705.775,009,916.057,479,904.306,545,158.908,879,870.573,601,456.79
 资产减值损失(元) 952,635.04-48,867,566.35-17,797,649.97-60,737,141.08-34,635,920.29-1,640,635.18-29,023,329.39
 信用减值损失(元) 7,989,554.90-10,712,220.68-19,644,058.3151,728,953.17-29,067,389.24-7,620,014.13-5,515,874.57
三、其他经营收益
 加:公允价值变动收益(元) 1,234,920.08-1,383,317.551,547,057.58-70,102,964.24-36,084,340.99-1,752,758.00622,500.00
 加:投资收益(元) -26,608,833.2990,826,813.297,610,239.9347,343,846.04-88,145,516.8373,153,947.21-7,286,525.19
  其中:对联营企业和合营企业的投资收益(元) -25,329,662.40-1,695,996.38-15,865,690.79-99,402,771.05-40,393,832.71-9,712,872.06-8,044,749.37
 资产处置收益(元) -13,637,285.56-16,474,528.3315,277,919.367,963.36-5,573,029.672,510,901.892,557,689.99
 其他收益(元) 19,571,964.7530,401,585.8823,370,830.1321,190,649.7729,031,561.0033,581,102.9416,910,401.80
四、营业利润(元) 78,812,662.67254,493,669.45295,762,745.82191,634,635.5380,421,446.40228,814,357.69181,607,982.50
 加:营业外收入(元) 133,893.13778,733.5950,202.673,621,882.34988,527.12861,686.023,000,064.34
 减:营业外支出(元) 1,650,065.8547,416,216.20166,327.00-553,192.231,758,489.255,530,835.36791,764.26
五、利润总额(元) 77,296,489.95207,856,186.84295,646,621.49195,809,710.1079,651,484.27224,145,208.35183,816,282.58
 减:所得税费用(元) 35,489,252.7218,281,230.7454,114,396.9842,555,415.9560,848,217.1740,754,590.5747,844,983.76
六、净利润(元) 41,807,237.23189,574,956.10241,532,224.51153,254,294.1518,803,267.10183,390,617.78135,971,298.82
(一)按经营持续性分类
  持续经营净利润(元) 41,807,237.23189,574,956.10241,532,224.51153,254,294.1518,803,267.10183,390,617.78135,971,298.82
(二)按所有权归属分类
  归属于母公司股东的净利润(元) 37,685,741.60187,112,963.30232,298,844.11157,966,325.2312,077,611.96183,872,308.67135,128,838.42
  少数股东损益(元) 4,121,495.632,461,992.809,233,380.40-4,712,031.086,725,655.14-481,690.89842,460.40
 扣除非经常性损益后的净利润(元) 35,432,815.14127,805,769.85169,061,721.0951,118,228.0073,412,451.4674,707,294.40113,675,449.19
七、每股收益
 一、基本每股收益(元) 0.020.180.190.140.010.150.11
 二、稀释每股收益(元) 0.060.160.170.140.020.150.11
八、其他综合收益(元) -1,085,779.064,554,396.78-1,388,894.91-2,097,291.906,311,890.166,217,084.53162,875.02
 归属于母公司股东的其他综合收益(元) -1,085,779.064,554,396.78-1,388,894.91-2,097,291.906,311,890.166,217,084.53162,875.02
九、综合收益总额(元) 40,721,458.17194,129,352.88240,143,329.60151,157,002.2525,115,157.26189,607,702.31136,134,173.84
 归属于母公司所有者的综合收益总额(元) 36,599,962.54191,667,360.08230,909,949.20155,869,033.3318,389,502.12190,089,393.20135,291,713.44
 归属于少数股东的综合收益总额(元) 4,121,495.632,461,992.809,233,380.40-4,712,031.086,725,655.14-481,690.89842,460.40
公告日期 2023-10-282023-08-222023-04-252023-03-312022-10-282022-08-232022-04-26
审计意见(境内) 标准无保留意见

前瞻产业研究院